Clincosm LogoSign in Get a demo

Papillary Thyroid Cancer and Central Lymp Node Dissection

Sponsor
Basaksehir Cam & Sakura Şehir Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05873283
Collaborator
(none)
250
Enrollment
1
Location
33.3
Actual Duration (Months)
7.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Papillary cancer is a disease that spreads through lymphatic ways and its treatment is surgery. We performed prophylactic central dissection in addition to bilateral total thyroidectomy in patients with bethesda 5 and bethesda 6 biopsy results. We evaluated the pathology results retrospectively.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    250 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Is Central Lymph Node Dissection Necessary in Suspected Papillary Thyroid Cancer and Papillary Thyroid Cancer?
    Actual Study Start Date :
    Jun 12, 2020
    Actual Primary Completion Date :
    Feb 1, 2022
    Actual Study Completion Date :
    Mar 24, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Reaching 100 patients was the first target [18 months]

      100 patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • B5 and B6 biopsy results
    Exclusion Criteria:
    • lobectomy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 BasaksehirCamSakuraSehirH Istanbul Turkey

    Sponsors and Collaborators

    • Basaksehir Cam & Sakura Şehir Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Basaksehir Cam & Sakura Şehir Hospital
    ClinicalTrials.gov Identifier:
    NCT05873283
    Other Study ID Numbers:
    • 20210310
    First Posted:
    May 24, 2023
    Last Update Posted:
    May 24, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Basaksehir Cam & Sakura Şehir Hospital
    papillary thyroid cancer
    Additional relevant MeSH terms:
    Thyroid Neoplasms
    Thyroid Cancer, Papillary
    Thyroid Diseases

    Study Results

    No Results Posted as of May 24, 2023